Tolemy Bio

Tolemy Bio Ltd is a company developing an AI-native platform for cell therapy process development and manufacturing optimisation.

The platform ingests experimental and bioreactor data including cell growth, phenotype, potency, and metabolite profiles, then applies causal AI models to identify the biological drivers of cell performance.

Outputs are actionable media formulation and process recommendations designed to improve critical quality attributes, reduce variability, and accelerate scale-up for T-cell, NK-cell, and stem cell therapy manufacturing.